Kindred Biosciences Announces Two New Appointments to Board of Directors
Kindred Biosciences Announces Two New Appointments to Board of Directors News provided by Share this article Share this article SAN FRANCISCO, Feb. 9, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has appointed Lyndon Lien, Ph.D., an experienced biotech CEO, entrepreneur and investor, and Nanxi Liu, CEO and Co-Founder of Enplug and Co-Founder of Nanoly Bioscience, to its Board of Directors, effective February 5, 2021. "We are very pleased to welcome Lyndon and Nanxi to our Bo...
Source: prnewswire.com